These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 11553454)
1. Can bacterial interference prevent infection? Reid G; Howard J; Gan BS Trends Microbiol; 2001 Sep; 9(9):424-8. PubMed ID: 11553454 [TBL] [Abstract][Full Text] [Related]
2. Probiotic agents to protect the urogenital tract against infection. Reid G Am J Clin Nutr; 2001 Feb; 73(2 Suppl):437S-443S. PubMed ID: 11157354 [TBL] [Abstract][Full Text] [Related]
3. Use of Lactobacillus to prevent infection by pathogenic bacteria. Reid G; Burton J Microbes Infect; 2002 Mar; 4(3):319-24. PubMed ID: 11909742 [TBL] [Abstract][Full Text] [Related]
4. Probiotics to counteract biofilm-associated infections: promising and conflicting data. Vuotto C; Longo F; Donelli G Int J Oral Sci; 2014 Dec; 6(4):189-94. PubMed ID: 25257882 [TBL] [Abstract][Full Text] [Related]
5. Lactobacilli - bacteria-host interactions with special regard to the urogenital tract. Merk K; Borelli C; Korting HC Int J Med Microbiol; 2005 Apr; 295(1):9-18. PubMed ID: 15861812 [TBL] [Abstract][Full Text] [Related]
6. The role of cranberry and probiotics in intestinal and urogenital tract health. Reid G Crit Rev Food Sci Nutr; 2002; 42(3 Suppl):293-300. PubMed ID: 12058988 [TBL] [Abstract][Full Text] [Related]
7. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Gill HS Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):755-73. PubMed ID: 14507586 [TBL] [Abstract][Full Text] [Related]
8. Bacterial interference for the prevention and treatment of infections. Falagas ME; Rafailidis PI; Makris GC Int J Antimicrob Agents; 2008 Jun; 31(6):518-22. PubMed ID: 18359612 [TBL] [Abstract][Full Text] [Related]
9. Understanding urogenital biofilms and potential impact of probiotics. Reid G; Heinemann C; Howard J; Gardiner G; Gan BS Methods Enzymol; 2001; 336():403-10. PubMed ID: 11398415 [No Abstract] [Full Text] [Related]
10. Symposium on infections in the compromised host. External barriers to infection. Adams A Nurs Clin North Am; 1985 Mar; 20(1):145-9. PubMed ID: 3844816 [TBL] [Abstract][Full Text] [Related]
11. Targeting the vaginal microbiota with probiotics as a means to counteract infections. Reid G; Dols J; Miller W Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):583-7. PubMed ID: 19741517 [TBL] [Abstract][Full Text] [Related]
12. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. Servin AL FEMS Microbiol Rev; 2004 Oct; 28(4):405-40. PubMed ID: 15374659 [TBL] [Abstract][Full Text] [Related]
13. Ecological control of the gastrointestinal tract. The role of probiotic flora. Bengmark S Gut; 1998 Jan; 42(1):2-7. PubMed ID: 9505873 [No Abstract] [Full Text] [Related]
14. Prebiotics and resistance to gastrointestinal infections. Gibson GR; McCartney AL; Rastall RA Br J Nutr; 2005 Apr; 93 Suppl 1():S31-4. PubMed ID: 15877892 [TBL] [Abstract][Full Text] [Related]
15. Antagonistic effects of Streptococcus and Lactobacillus probiotics in pharyngeal biofilms. Humphreys GJ; McBain AJ Lett Appl Microbiol; 2019 Apr; 68(4):303-312. PubMed ID: 30776138 [TBL] [Abstract][Full Text] [Related]
16. Effects of single- and multi-strain probiotics on biofilm formation and in vitro adhesion to bladder cells by urinary tract pathogens. Chapman CM; Gibson GR; Rowland I Anaerobe; 2014 Jun; 27():71-6. PubMed ID: 24583095 [TBL] [Abstract][Full Text] [Related]
17. Monostrain, multistrain and multispecies probiotics--A comparison of functionality and efficacy. Timmerman HM; Koning CJ; Mulder L; Rombouts FM; Beynen AC Int J Food Microbiol; 2004 Nov; 96(3):219-33. PubMed ID: 15454313 [TBL] [Abstract][Full Text] [Related]
18. Probiotics interaction with foodborne pathogens: a potential alternative to antibiotics and future challenges. Wan MLY; Forsythe SJ; El-Nezami H Crit Rev Food Sci Nutr; 2019; 59(20):3320-3333. PubMed ID: 29993263 [TBL] [Abstract][Full Text] [Related]
19. Anti-adhesion methods as novel therapeutics for bacterial infections. Cozens D; Read RC Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1457-68. PubMed ID: 23253323 [TBL] [Abstract][Full Text] [Related]